The DVS Sciences CyTOF 2 system uses the same mass cytometry technology for the global adoption of the CyTOF Mass Cytometer.
The technology enables comprehensive functional and phenotypic characterization of complex systems at the single cell level in diverse disciplines including immunology, cancer research, stem cell biology and drug profiling.
The CyTOF 2 platform has the ability to measure up to 120 cell biomarkers in single cells at up to 1000 cells per second simultaneously.
DVS Cytobank, a cloud based analytical software platform, is also available to automatically analyze and manage data sets resulting from the CyTOF platform.
Five new MaxPar Panel Kits are now available that provide up to 17 ready to use metal-conjugated antibodies and can be combined with up to 16 additional antibodies simultaneously by allowing high resolution single cell assays of multiple cell populations in a single tube.
DVS Sciences president and CEO Joseph Victor said that with the new products, the company will grow to scale its customer support and provide additional resources to their new and existing customers.